Ciprofloxacin or Tamsulosin in Men with Chronic Prostatitis/Chronic Pelvic Pain Syndrome: A Randomized, Double-Blind Trial

Established in 1927 by the American College of Physicians

Abstract/Editors' Note | Full Text | PDF

FIGURES/TABLES SUMMARY PAGE

PowerPoint slides are available for most Figures at Annals.org

Ciprofloxacin or Tamsulosin in Men with Chronic Prostatitis/Chronic Pelvic Pain Syndrome

A Randomized, Double-Blind Trial

View this table:

[in a new window]

Table 1. Study Design

View this table:

[in a new window]

Table 2. Baseline Characteristics by Individual Treatment Groups

View larger version (39K):

[in a new window]

Figure 1. Flow of patients through the study, according to individual treatment group. The number of patients to whom the study was presented and discussed was not captured.

View this table:

[in a new window]

Table 3. Primary End Point: Change from Baseline to 6 Weeks in Total Score on the National Institutes of Health Chronic Prostatitis Symptom Index

View this table:

[in a new window]

Table 4. Secondary End Points: Changes from Baseline to 6 Weeks, Main Effects

View this table:

[in a new window]

Table 5. Secondary End Points: Changes from Baseline to 6 Weeks in Individual Groups

View larger version (18K):

[in a new window]

Figure 2. Mean values of the National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI) total score (potential of 43 points) over time for the 4 individual treatment groups. All available data on all patients are included in the means; the sample sizes at each time point are as shown.

View this table:

[in a new window]

Appendix Table. Adverse Events by Treatment Group